Quantum Cyber N.V. Increase Decrease Through Conversion Of Convertible Instruments
Quantum Cyber N.V. (QUCY) reported Increase Decrease Through Conversion Of Convertible Instruments of $2.15 million for the 6-month period ending 2024-06-30, per its 6-K filed 2025-09-26.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments · last filed 2025-09-26
- Quantum Cyber N.V. increase decrease through conversion of convertible instruments for the quarter ending 2023-09-30 was $0.00.
| Period end | Increase Decrease Through Conversion Of Convertible Instruments 3 month | Increase Decrease Through Conversion Of Convertible Instruments 6 month | Increase Decrease Through Conversion Of Convertible Instruments 9 month | Increase Decrease Through Conversion Of Convertible Instruments 12 month |
|---|---|---|---|---|
| 2024-06-30 | $2.15M 6-K · filed 2025-09-26 | |||
| 2023-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2023-11-16 | $250.00K 6-K · filed 2023-11-16 | ||
| 2023-06-30 | $250.00K 6-K · filed 2023-08-15 | |||
| 2021-12-31 | -$508.24K 20-F · filed 2023-04-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |